Previous 10 | Next 10 |
2023-05-25 08:13:15 ET Biocept ( BIOC ) -41% on pricing $5.0M stock offering . QuantaSing Group ( QSG ) -32% . Digital Turbine ( APPS ) -31% after Q4 earning release . Annexon ( ANNX ) -23% . as geographic atrophy candidate fails in ph...
2023-05-24 09:54:18 ET Phio Pharmaceuticals ( NASDAQ: PHIO ) stock rose ~12% on Wednesday after the company said its clinical development partner AgonOx in collaboration with Providence Cancer Institute completed a site initiation visit and can start patient accrual. The t...
Phio Pharmaceuticals Announces Initiation of Collaborative Clinical Trial with PH-762, AgonOx's Tumor Infiltrating Lymphocyte Program (AGX148) and Providence Cancer Institute PR Newswire One of two newly announced clinical trials for its lead product candidate, PH-762 ...
2023-05-19 10:04:48 ET Gainers: Lucy Scientific Discovery ( LSDI ) +51% . Bioventus ( BVS ) +44% . Mallinckrodt ( MNK ) +28% . 180 Life Sciences ( ATNF ) +28% . Stereotaxis ( STXS ) +25% . Losers: Enveric Biosciences ( ENVB ...
2023-05-19 08:20:32 ET Foot Locker FL -25% after Q1 earning release . Phio Pharmaceuticals ( PHIO ) -12% . Infobird ( IFBD ) -12% . Alimera Sciences ( ALIM ) -11% . Enveric Biosciences ( ENVB ) -10% . Eledon Pharmaceuticals ( E...
2023-05-18 12:42:08 ET Gainers: Enveric Biosciences ( ENVB ) +112% . Phio Pharmaceuticals ( PHIO ) +46% . WANG & LEE GROUP ( WLGS ) +34% . Alimera Sciences ( ALIM ) +29% . SciPlay Corporation ( SCPL ) +26% . Eltek ( ELT...
Phio Pharmaceuticals Presents Preclinical Study Showing INTASYL™ Treatment of NK Cells More than Doubles Ability to Kill Tumor Cells PR Newswire Data is being presented at 2023 American Society of Gene and Cell Therapy (ASGCT) Annual Meeting MARLBOROUGH, Mas...
2023-05-16 13:08:04 ET Gainers: GD Culture Group Limited ( GDC ) +84% . The Singing Machine Company ( MICS ) +62% . Applied Digital Corporation ( APLD ) +51% . Exela Technologies ( XELA ) +40% . AN2 Therapeutics ( ANTX ) +26% . ...
2023-05-16 10:07:34 ET Gainers: Phio Pharmaceuticals ( PHIO ) +30% . Coya Therapeutics ( COYA ) +23% . Nanobiotix ( NBTX ) +12% . Savara ( SVRA ) +12% . Bellerophon Therapeutics ( BLPH ) +11% . Losers: Eloxx Pharmaceutical...
2023-05-16 09:01:37 ET Phio Pharma ( NASDAQ: PHIO ) witnessed a significant premarket surge of 28% following its announcement that the U.S. Food and Drug Administration (FDA) had granted clearance for its Investigational New Drug ( IND ) application. This clearance pav...
News, Short Squeeze, Breakout and More Instantly...
Phio Pharmaceuticals Corp. Company Name:
PHIO Stock Symbol:
NASDAQ Market:
Phio's Compound RXI-185 is designed to slow progression of UV induced collagen breakdown Marlborough, Massachusetts--(Newsfile Corp. - June 18, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical stage biotechnology company whose proprietary INTASYL ® siRNA gene silencing techno...
Intratumoral PH-762 has encouraging safety profile in the initial cohort Escalation to proceed to next dose concentration Marlborough, Massachusetts--(Newsfile Corp. - May 28, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical stage biotechnology company whose proprietary I...
Phio to present a clinical study progress update on their lead clinical candidate, PH-762 Marlborough, Massachusetts--(Newsfile Corp. - May 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical stage biotechnology company whose proprietary INTASYL™ siRNA gene silencing technol...